Evidence map›Paper›PMID 34256559›Full record

ArticleACS applied materials & interfaces2021

3D Printed Microfluidic Device for Magnetic Trapping and SERS Quantitative Evaluation of Environmental and Biomedical Analytes.

Lucio Litti, Stefano Trivini, Davide Ferraro, Javier Reguera

Open access · hybridAbstract read
In one paragraph

Article in ACS applied materials & interfaces, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 65 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Lucio LittiDepartment of Chemical Sciences, University of Padova, via Marzolo 1, 35131 Padova, Italy.ORCID https://orcid.org/0000-0001-6247-5456
Stefano TriviniDepartment of Chemical Sciences, University of Padova, via Marzolo 1, 35131 Padova, Italy.
Davide FerraroDepartment of Physics and Astronomy, University of Padova, via Marzolo 8, 35131 Padova, Italy.
Javier RegueraBCMaterials, Basque Center for Materials, Applications and Nanostructures, UPV/EHU Science Park, 48940 Leioa, Spain.ORCID https://orcid.org/0000-0001-5110-5361
University of Padua · ITBasque Center for Materials, Applications and Nanostructures · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Surface-enhanced Raman scattering (SERS) is an ideal technique for environmental and biomedical sensor devices due to not only the highly informative vibrational features but also to its ultrasensitive nature and possibilities toward quantitative assays. Moreover, in these areas, SERS is especially useful as water hinders most of the spectroscopic techniques such as those based on IR absorption. Despite its promising possibilities, most SERS substrates and technological frameworks for SERS detection are still restricted to research laboratories, mainly due to a lack of robust technologies and standardized protocols. We present herein the implementation of Janus magnetic/plasmonic Fe

Indexed as

Antineoplastic AgentsBenzoatesBenzoxazinesErlotinib HydrochlorideGentian VioletGoldHerbicidesHumansLab-On-A-Chip DevicesLimit of DetectionMagnetite NanoparticlesMicrofluidic Analytical TechniquesPhthalimidesPrinting, Three-DimensionalSpectrum Analysis, RamanSulfhydryl Compounds4-mercaptobenzoateAntineoplastic AgentsBenzoatesBenzoxazinesErlotinib HydrochlorideflumioxazinGentian VioletGoldHerbicidesMagnetite NanoparticlesPhthalimidesSulfhydryl Compounds3D printingerlotinibflumioxazinJanus nanoparticlesmicrofluidicpartial least-squares regressionSERS

Identifiers

PMID34256559
PMCPMC8397251
OpenAlexW3178551677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.